3-Heterocyclyl-indole inhibitors of glycogen synthase kinase-3

Details 3-Heterocyclyl-indole inhibitors of glycogen synthase kinase-3 3-Heterocyclyl-indole inhibitors of glycogen synthase kinase-3

2008-07-15

2008-07-15

McKane, Joseph (Department: 1626)

Drug, bio-affecting and body treating compositions

Designated organic active ingredient containing

Having -c-, wherein x is chalcogen, bonded directly to...

C514S418000, C548S469000, C548S484000

Reexamination Certificate

active

10509268

ABSTRACT:
The present invention provides new compounds of formula Ia and Ib: as well as a process for their preparation and new intermediates used therein, pharmaceutical formulations containing said therapeutically active compounds and to the use of said active compounds in therapy.

REFERENCES:
patent: 6265411 (2001-07-01), Thomas et al.
patent: 6294532 (2001-09-01), Thomas et al.
patent: 6987110 (2006-01-01), Zhang et al.
patent: 7205314 (2007-04-01), Berg et al.
patent: 2005/0070559 (2005-03-01), Berg et al.
patent: 2005/0075351 (2005-04-01), Berg et al.
patent: 2005/0222181 (2005-10-01), Berg et al.
patent: 0667340 (1995-08-01), None
patent: 1136493 (2001-09-01), None
patent: 9515758 (1995-06-01), None
patent: 9523141 (1995-08-01), None
patent: 9533750 (1995-12-01), None
patent: WO-97/42187 (1997-11-01), None
patent: 9910349 (1999-03-01), None
patent: 0010975 (2000-03-01), None
patent: WO-00/71129 (2000-11-01), None
patent: WO-01/25220 (2001-04-01), None
patent: WO-01/32653 (2001-05-01), None
patent: WO-02/10158 (2002-02-01), None
patent: 0230868 (2002-04-01), None
patent: 03053330 (2003-07-01), None
patent: 03053444 (2003-07-01), None
patent: 03055492 (2003-07-01), None
patent: 03055877 (2003-07-01), None
Co-pending U.S. Appl. No. 10/572,778.
Bruni, et al (Annali di Chimica, 1967, vol. 57, Issue 6, pp. 688-697, especially p. 693).
Copending U.S. Appl. No. 10/572,778.
STN International, File CHEMCATS, accession No. 2001:15770, May 14, 2001, Pharma Library Collection, “2(1H)-Quinoxalinone, 3-(2-hydroxy-1H-indol-3-yl)-”, CAS Registry No. RN 312706-99-3.
STN International, File CAPLUS, CAPLUS accession No. 1967:516779, Document No. 67:116779, Bruni, Paolo et al.: Enolizable cyclic ketones. I. Reaction with activated heteroaromatic N-oxides; & Ann. Chim. (Rome) (1967), 57(6), 688-97.
Ali et al., “Glycogen Synthase Kinase-3: properity, functions, and regulation,” Chemical Reviews, Dec. 21, 2000, published online.
“Alzheimers Disease” Wikipedia, online encyclopedia.
Hewawasam et al., “Synthesis and Structure-Activity Relationships of 3-Aryloxindoles: A New Class of Calcium-Dependent, Large Conductance Potassium (Maxi-K) Channel Openers with Neuroprotective Properties,” J. Med. Chem., 2002, vol. 45, pp. 1487-1499.
OA issued for U.S. Appl. No. 10/499,685 on Jan. 6, 2006.
Final OA issued for U.S. Appl. No. 10/499,685 on Jul. 20, 2006.
OA issued for U.S. Appl. No. 10/499,685 on Aug. 1, 2007.
OA issued for U.S. Appl. No. 10/499,217 on Jun. 13, 2006.
OA issued for U.S. Appl. No. 10/499,388 on Sep. 20, 2005.
Final OA issued for U.S. Appl. No. 10/499,388 on Oct. 12, 2006.

Affiliated with

Also associated with

Rating

3-Heterocyclyl-indole inhibitors of glycogen synthase kinase-3 does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with 3-Heterocyclyl-indole inhibitors of glycogen synthase kinase-3, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and 3-Heterocyclyl-indole inhibitors of glycogen synthase kinase-3 will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-3947503